Concepedia

Author

Gene P. Siegal

University of Alabama at BirminghamORCID

Also Known As

G P Siegal, G SIEGAL, G. P. Siegal, G. Siegal, G.P. Siegal, GENE P. SIEGAL, Gene P Siegal, Gene P. Siegal, Gene P. Siegal, MD, PhD, Gene Siegal

464

Publications

17.3K

Citations

63

H-Index

239

Concepts

All Affiliations

University of Alabama at BirminghamUniversity of North Carolina at Chapel Hill
GP

About

Gene P. Siegal is an author at University of Alabama at Birmingham specializing in medicine, pathology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

47

142

8.1K

2

Health Sciences

15

16

1.3K

3

Engineering

7

7

284

4

Natural Sciences

6

6

534

5

Public Health

2

2

389

Gene P. Siegal

×

227

Publications

15.4K

Citations

61

H-Index

YearCitations

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo,

Journal of Clinical Oncology

2008

734

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo,

Journal of Clinical Oncology

2005

711

Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Lance A. Liotta, R H Goldfarb, Rodney A. Brundage,

PubMed

1981

589

Loss of basement membrane components by invasive tumors but not by their benign counterparts.

Sanford H. Barsky, Gene P. Siegal, Frank S. Jannotta,

PubMed

1983

497

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

Corey K. Goldman, Richard Kendall, Gustavo Cabrera,

Proceedings of the National Academy of Sciences

1998

443

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy

Luigi Padeletti, Davíð O. Arnar, Lorenzo Boncinelli,

EP Europace

2010

377

Osteosarcoma

Michael Klein, Gene P. Siegal

American Journal of Clinical Pathology

2006

371

Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanism

Jessy S. Deshane, Sergio Caballero, Anna Grochot‐Przeczek,

The Journal of Experimental Medicine

2007

282

Breast Cancer Subtypes Predispose the Site of Distant Metastases

Abha Soni, Zhiyong Ren, Omar Hameed,

American Journal of Clinical Pathology

2015

270

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

David Ebb, Paul A. Meyers, Holcombe E. Grier,

Journal of Clinical Oncology

2012

244

Page 1